日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prospective validation of initial eculizumab dosing in adults with atypical hemolytic uremic syndrome

前瞻性验证依库珠单抗初始剂量在非典型溶血性尿毒综合征成人患者中的应用

Ter Avest, Mendy; Duineveld, Caroline; Bouwmeester, Romy N; Baas, Laura M; van den Heuvel, Lambertus P W J; Langemeijer, Saskia M C; Wetzels, Jack F M; van de Kar, Nicole C A J; Ter Heine, Rob

Kidney Transplantation in Patients With aHUS: A Comparison of Eculizumab Prophylaxis Versus Rescue Therapy

肾移植治疗非典型溶血性尿毒综合征(aHUS):依库珠单抗预防与抢救治疗的比较

Duineveld, Caroline; Glover, Emily K; Bouwmeester, Romy N; van de Kar, Nicole C A J; Kavanagh, David; Wetzels, Jack F M; Sheerin, Neil S

General practitioner-led vs surgeon-led colon cancer survivorship care: a randomized clinical trial

全科医生主导与外科医生主导的结肠癌生存期护理:一项随机临床试验

Vos, Julien A M; Duineveld, Laura A M; Wieldraaijer, Thijs; Wind, Jan; Busschers, Wim B; Sert, Edanur; Verdonck-de Leeuw, Irma M; van Weert, Henk C P M; van Asselt, Kristel M

Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study

非典型溶血性尿毒综合征肾移植患者补体失调的体外检测:一项初步研究

Duineveld, Caroline; Bouwmeester, Romy N; van den Heuvel, Lambertus P W J; van de Kar, Nicole C A J; Wetzels, Jack F M

A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: "Eculizumab first" in the management of posttransplant thrombotic microangiopathy

谨慎使用C5b-9内皮细胞检测支持依库珠单抗治疗:对Maritati等人“移植后血栓性微血管病治疗中优先使用依库珠单抗”的回应

Duineveld, Caroline; van de Kar, Nicole C A J; Wetzels, Jack F M

Cost-effectiveness of general practitioner- versus surgeon-led colon cancer survivorship care: an economic evaluation alongside a randomised controlled trial

全科医生主导与外科医生主导的结肠癌生存期护理的成本效益:一项随机对照试验的经济评估

Vos, Julien A M; El Alili, Mohamed; Duineveld, Laura A M; Wieldraaijer, Thijs; Wind, Jan; Sert, Edanur; Donkervoort, Sandra C; Govaert, Marc J P M; van Geloven, Nanette A W; van de Ven, Anthony W H; Heuff, Gijsbert; van Weert, Henk C P M; Bosmans, Judith E; van Asselt, Kristel M

Is CRT Optimization Obsolete? A Referral Center's Experience

CRT优化过时了吗?一家转诊中心的经验

Saleem-Talib, Shmaila; Duineveld, Mirjam D; Schipper, Jurjan C; Hauer, Arnaud D; Ramanna, Hemanth; de Groot, Natasja M S; Scheffer, Michael G

Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome

非典型溶血性尿毒综合征患者的蛋白尿和依库珠单抗暴露

Ter Avest, Mendy; Steenbreker, Hilbert; Bouwmeester, Romy N; Duineveld, Caroline; Wijnsma, Kioa L; van den Heuvel, Lambertus P W J; Langemeijer, Saskia M C; Wetzels, Jack F M; van de Kar, Nicole C A J; Ter Heine, Rob

Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study

在患有非典型溶血性尿毒综合征且肾脏功能正常的患者中,早期停用依库珠单抗是安全且具有成本效益的:CUREiHUS 研究结果

Bouwmeester, Romy N; Duineveld, Caroline; Wijnsma, Kioa L; Bemelman, Frederike J; van der Heijden, Joost W; van Wijk, Joanna A E; Bouts, Antonia H M; van de Wetering, Jacqueline; Dorresteijn, Eiske; Berger, Stefan P; Gracchi, Valentina; van Zuilen, Arjan D; Keijzer-Veen, Mandy G; de Vries, Aiko P J; van Rooij, Roos W G; Engels, Flore A P T; Altena, Wim; de Wildt, Renée; van Kempen, Evy; Adang, Eddy M; Ter Avest, Mendy; Ter Heine, Rob; Volokhina, Elena B; van den Heuvel, Lambertus P W J; Wetzels, Jack F M; van de Kar, Nicole C A J

Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation

依库珠单抗挽救治疗肾移植后复发性非典型溶血性尿毒综合征患者

Duineveld, Caroline; Bouwmeester, Romy N; Wijnsma, Kioa L; Bemelman, F J; van der Heijden, J W; Berger, S P; van den Heuvel, L P W J; van de Kar, Nicole C A J; Wetzels, Jack F M